BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 715,900 shares, a growth of 205.8% from the February 13th total of 234,100 shares. Based on an average daily volume of 390,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 14.3% of the shares of the company are short sold.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in BioRestorative Therapies stock. Citadel Advisors LLC bought a new position in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTX) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned 0.31% of BioRestorative Therapies at the end of the most recent quarter. 69.38% of the stock is currently owned by institutional investors.

BioRestorative Therapies Price Performance

Shares of NASDAQ BRTX opened at $1.77 on Friday. The company has a market cap of $12.25 million, a PE ratio of -1.16 and a beta of 64.37. The stock has a fifty day moving average price of $1.97 and a 200 day moving average price of $1.71. BioRestorative Therapies has a 1-year low of $1.03 and a 1-year high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.